Denali Therapeutics Inc.

NASDAQ: DNLI · Real-Time Price · USD
14.71
0.25 (1.73%)
At close: Aug 15, 2025, 3:59 PM
14.70
-0.03%
After-hours: Aug 15, 2025, 04:10 PM EDT

Denali Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-7.93 -20.3 -10.71 -18.65
PEG Ratio
-0.06 0.34 -1.22 0.04
PS Ratio
n/a 8.92 32.19 111.38
PB Ratio
2.73 2.86 3.35 5.63
P/FCF Ratio
-9.22 -7.95 -13.3 -24.65
P/OCF Ratio
-9.64 -8.23 -14.27 -25.64
OCF/S Ratio
n/a -1.08 -2.26 -4.34
Debt / Equity Ratio
0.04 0.05 0.06 0.06
Quick Ratio
8.46 13.65 3.78 2.37
Current Ratio
8.46 13.65 3.77 2.37
Asset Turnover
n/a 0.29 0.07 0.03
Interest Coverage
n/a n/a n/a n/a
Return on Equity
-0.34 -0.14 -0.31 -0.3
Return on Assets
-0.31 -0.13 -0.22 -0.21
Return on Invested Capital
-0.38 -0.18 -0.31 -0.29
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
n/a 0.95 0.94 0.88
Net Profit Margin
n/a -0.44 -3.01 -5.97
Pretax Profit Margin
n/a -0.44 -3.01 -5.98
Operating Profit Margin
n/a -0.6 -3.14 -6.08
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a -0.54 -3.05 -5.9